Skip to main content
SpringerLink
Log in

Mean Time Parameters in Pharmacokinetics

Definition, Computation and Clinical Implications (Part II)

  • Review Article
  • Clinical Pharmacokinetic Concepts
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Part I of this article, which appeared in the previous issue of the Journal, covered the following topics: fundamental definitions, general mean time parameter relationships and mean time parameters of classical compartmental systems. It also offered a number of examples to clarify and illustrate the various concepts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aarons L. Mean residence time for drugs subject to reversible metabolism. Journal of Pharmacy and Pharmacology 39: 565–657, 1987

    Article  PubMed  CAS  Google Scholar 

  • Beal SL. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. Drug Metabolism Review 15: 173–193, 1984

    Article  CAS  Google Scholar 

  • Beal SL. Some clarifications regarding moments of residence times with pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics 15: 75–92, 1987

    PubMed  CAS  Google Scholar 

  • Benet LZ, Galeazzi RL. Noncompartmental determination of the steady state volume of distribution. Journal of Pharmaceutical Sciences 68: 1071–1074, 1979

    Article  PubMed  CAS  Google Scholar 

  • Bialer M, Look ZM, Silber BM, Yacobi A. The relationship between drug input and mean residence time in the body. Biopharmaceutics and Drug Disposition 7: 577–583, 1986

    Article  CAS  Google Scholar 

  • Brockmeier D. In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times. Arzneimittel-Forschung 34: 1604–1607, 1984

    PubMed  CAS  Google Scholar 

  • Brockmeier D. Presystemic elimination and mean residence time. Biopharmaceutics and Drug Disposition 6: 229–230, 1985

    Article  CAS  Google Scholar 

  • Brockmeier D. Model-free evaluation and mean time concepts in pharmacokinetics. Methods and Findings in Experimental and Clinical Pharmacology 8: 593–602, 1986

    PubMed  CAS  Google Scholar 

  • Brockmeier D, Ostrowski J. Mean time and first-pass metabolism. European Journal of Clinical Pharmacology 29: 45–48, 1985

    Article  PubMed  CAS  Google Scholar 

  • Brockmeier D, van-Hattingberg HH. Mean residence time. Methods and Findings in Experimental and Clinical Pharmacology 8: 309–312, 1986

    PubMed  CAS  Google Scholar 

  • Burke JT, Wargin WA, Sherertz RJ, Sanders KL, Blum MR, et al. Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function. Journal of Pharmacokinetics and Biopharmaceutics 10: 601–614, 1982

    PubMed  CAS  Google Scholar 

  • Chan KK. A simple integrated method for drug and derived metabolite kinetics: an application of the statistical moment theory. Drug Metabolism and Disposition 10: 474–479, 1982

    PubMed  CAS  Google Scholar 

  • Chan KK, Gilbaldi M. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion. Journal of Pharmacokinetics and Biopharmaceutics 10: 551–558, 1982

    PubMed  CAS  Google Scholar 

  • Chennavasin P, Johnson RA, Brater DC. Variability in derived parameters of furosemide pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 9: 623–633, 1981

    PubMed  CAS  Google Scholar 

  • Chiou WL, Lam G, Chen ML, Lee MG. Effect of arterial-venous plasma concentration differences on the determination of mean residence time of drugs in the body. Research Communications in Chemical Pathology and Pharmacology 35: 17–26, 1982

    PubMed  CAS  Google Scholar 

  • Cutler DJ. Theory of the mean absorption time, an adjunct to conventional bioavailability studies. Journal of Pharmacy and Pharmacology 30: 476–478, 1978

    Article  PubMed  CAS  Google Scholar 

  • Cutler DJ. A linear recirculation model for drug disposition. Journal of Pharmacokinetics and Biopharmaceutics 7: 101–116, 1979

    PubMed  CAS  Google Scholar 

  • Cutler DJ. Definition of mean residence times in pharmacokinetics. Biopharmaceutics and Drug Disposition 8: 87–97, 1987

    Article  CAS  Google Scholar 

  • D’Argenio DZ, Katz D. Sampling strategies for noncompartmental estimation of mean residence time. Journal of Pharmacokinetics and Biopharmaceutics 11: 435–446, 1983

    PubMed  Google Scholar 

  • Devereux J, Newton JM. Statistical analysis of gastrointestinal transit time of pharmaceutical formulations. Journal of Pharmacy and Pharmacology 38: 327–328, 1986

    Article  PubMed  CAS  Google Scholar 

  • Eisenfeld AJ. On mean residence time in compartments. Mathematical Biosciences 57: 265–278, 1981

    Article  Google Scholar 

  • Gillespie WR, Veng-Pedersen P. The determination of mean residence time using statistical moments: it is correct. Journal of Pharmacokinetics and Biopharmaceutics 13: 549–554, 1985a

    PubMed  CAS  Google Scholar 

  • Gillespie WR, Veng-Pedersen P. A polyexponential deconvolution method. Evaluation of ‘gastrointestinal bioavailability’ and mean in vivo dissolution time of some ibuprofen dosage forms. Journal of Pharmacokinetics and Biopharmaceutics 13: 289–307, 1985b

    PubMed  CAS  Google Scholar 

  • Gillespie WR, Veng-Pedersen P. Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics. Journal of Pharmacokinetics and Biopharmaceutics 13: 441–451, 1985c

    PubMed  CAS  Google Scholar 

  • Goyette A. Pharmacokinetics: statistical moment calculations. Arzneimittel-Forschung 33: 173–176, 1983

    Google Scholar 

  • Guentert TW, Haiford NHG, Coates PE, Upton RA, Riegelman S. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies. Journal of Pharmacokinetics and Biopharmaceutics 7: 315–330, 1979

    PubMed  CAS  Google Scholar 

  • Hearon JZ. Residence times in compartmental systems and the moments of a certain distribution. Mathematical Biosciences 15: 66–77, 1972

    Article  Google Scholar 

  • Hearon JZ. Residence times in compartmental systems with and without inputs. Mathematical Biosciences 52: 247–257, 1981

    Article  Google Scholar 

  • Herman RA, Veng-Pedersen P, Hoffman J, Furst DE. Pharmacokinetics of low dose methotrexate in rheumatoid arthritis patients. Journal of Pharmaceutical Sciences 78: 165–171, 1989

    Article  PubMed  CAS  Google Scholar 

  • Himmelblau DM, Bischoff KB (Eds) Process analysis and simulation. In Deterministic systems, Wiley, New York, 1968

  • Huffman DH, Crow JW, Pentikainen P, Azarnoff DL. Association between clinical cardiac status, laboratory parameters and digoxin usage. American Heart Journal 91: 28–34, 1975

    Article  Google Scholar 

  • Jackson AJ, Chen ML. Application of moment analysis in assessing rates of absorption for bioequivalence studies. Journal of Pharmaceutical Sciences 76: 6–9, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kakutani T, Yamaoka K, Hashida M, Sezabi H. A new method for assessment of drug disposition in muscle: application of statistical moment theory to local perfusion systems. Journal of Pharmacokinetics and Biopharmaceutics 13: 609–631, 1985

    PubMed  CAS  Google Scholar 

  • Yasuya Y, Hirayana H, Kubota N, Pang KS. Interpretation and estimates of mean residence time with statistical moment theory. Biopharmaceuticals and Drug Disposition 8: 223–234, 1987

    Article  Google Scholar 

  • Keilson J, Kester A, Waterhouse C. A circulatory model for human metabolism. Journal of Theoretical Biology 74: 535–547, 1978

    Article  PubMed  CAS  Google Scholar 

  • Kelman AW, Whiting B. Modeling of drug response in individual subjects. Journal of Pharmacokinetics and Biopharmaceutics 8: 115–130, 1980

    PubMed  CAS  Google Scholar 

  • Khoo KC, Gibaldi M, Brazzell KK. Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vitro dissolution rates. Journal of Pharmaceutical Sciences 74: 1340–1342, 1985

    Article  PubMed  CAS  Google Scholar 

  • Knolle H. A new estimation method for noncompartmental pharmacokinetic analysis. Biomedical Journal 1: 31–38, 1986

    Google Scholar 

  • Koup JR, Greenblatt DJ, Jusko WJ, Smith TW, Koch-Weser J. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. Journal of Pharmacokinetics and Biopharmaceutics 3: 181–189, 1975

    PubMed  CAS  Google Scholar 

  • Landaw EM, Katz D. Comments on mean residence time determination. Journal of Pharmacokinetics and Biopharmaceutics 13: 543–547, 1985

    PubMed  CAS  Google Scholar 

  • Lassen NA, Perl W. Tracer kinetic methods in medical physiology, Raven Press, New York, 1979

    Google Scholar 

  • Loo JCK, Riegelman S. New method for calculating the intrinsic absorption rate of drugs. Journal of Pharmaceutical Sciences 57: 918–928, 1968

    Article  PubMed  CAS  Google Scholar 

  • Matis JH, Wehrly TE, Metzler CM. On some stochastic formulations and related statistical moments of pharmacokinetic models. Journal of Pharmacokinetics and Biopharmaceutics 11: 77–92, 1983

    PubMed  CAS  Google Scholar 

  • Narang PK, Adir J, Josselson J, Yacobi A, Sadler J. Pharmacokinetics of bretylium in man after intravenous administration. Journal of Pharmacokinetics and Biopharmaceutics 8: 363–372, 1980

    PubMed  CAS  Google Scholar 

  • Oppenheimer JJ, Schwartz HL, Surks MI. Determination of common parameters of iodothyronine metabolism and distribution in man by noncompartmental analysis. Journal of Clinical Endocrinology 41: 319–323, 1975

    Article  CAS  Google Scholar 

  • Patel IH, Bornemann L, Colburn WA. Evaluation of drug absorption by nonlinear regression, statistical moments, and Loo-Riegelman methods. Journal of Pharmaceutical Sciences 74: 359–360, 1985

    Article  PubMed  CAS  Google Scholar 

  • Perl W, Samuel P. Input-output analysis for total input rate traced mass of body cholesterol in man. Circulation Research 25: 191–199, 1969

    Article  PubMed  CAS  Google Scholar 

  • Pfeffer M. Estimation of mean residence time from data obtained when multiple dosing steady state has been reached. Journal of Pharmaceutical Sciences 73: 854–856, 1984

    Article  PubMed  CAS  Google Scholar 

  • Piotrovskii VK. Pharmacokinetic stochastic model with Weibull-distributed residence times of drug molecules in the body. European Journal of Clinical Pharmacology 32: 515–523, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ramakrishnan R, Leonard EF, Dell RB. A proof of the occupancy principle and the mean transit time theorem for compartmental models. Mathematical Biosciences 68: 121–136, 1984

    Article  PubMed  Google Scholar 

  • Rescigno A. On transfer times in tracer experiments. Journal of Theoretical Biology 39: 9–27, 1973

    Article  PubMed  CAS  Google Scholar 

  • Rescigno A, Gurpide E. Estimation of average times of residence, recycle and interconversion of blood born compounds using tracer methods. Journal of Clinical Endocrinology and Metabolism 36: 263–276, 1973

    Article  PubMed  CAS  Google Scholar 

  • Rescigno A, Segré G. In Drug and tracer kinetics, p. 161, Blaisdell, Waltham, MA, 1966

    Google Scholar 

  • Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vitro dissolution time and absorption time. Journal of Pharmacokinetics and Biopharmaceutics 8: 509–535, 1980

    PubMed  CAS  Google Scholar 

  • Roberts GW, Larson KB, Spaeth EE. The interpretation of mean transit time measurement for multiphase tissue systems. Journal of Theoretical Biology 39: 447–475, 1973

    Article  PubMed  CAS  Google Scholar 

  • Rowland M, Riegelman S, Epstein WL. Absorption kinetics of griseofulvin in man. Journal of Pharmaceutical Sciences 57: 984–989, 1968

    Article  PubMed  CAS  Google Scholar 

  • Segré G. In Rowland and Tucker (Eds) Pharmacokinetics, theory and methodology, Chapter 3, Pergamon Press, New York, 1986

  • Sheiner LB, Benet LZ, Pagliaro LA. Pharmacokinetic data: a standard approach to compiling clinical pharmacokinetic data. Journal of Pharmacokinetics and Biopharmaceutics 9: 59–127, 1981

    PubMed  CAS  Google Scholar 

  • Siegel RA. The urinary elimination ‘time lag’: determination of the mean residence time from drug accumulation in the urine during infusion. Journal of Pharmaceutical Sciences 75: 627–628, 1986

    Article  PubMed  CAS  Google Scholar 

  • Strum JD, Colaizzi JL, Jaffe JM, Martineau PC, Poust RI. Comparative bioavailability of four commercial quinidine sulfate tablets. Journal of Pharmaceutical Sciences 60: 539–542, 1977

    Article  Google Scholar 

  • Tanigawara Y, Yamaoka K, Nakagawa T, Uno T. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption and disposition time of ampicillin products. Journal of Pharmaceutical Sciences 71: 1129–1133, 1982a

    Article  PubMed  CAS  Google Scholar 

  • Tanigawara Y, Yamaoka T, Nakagawa T, Uno T. New method for evaluation of in vitro dissolution and disintegration time. Chemical Pharmacy Bulletin 30: 1088–1090, 1982b

    Article  CAS  Google Scholar 

  • Tsuei SE, Moore RG, Ashley JJ, McBride WG. Disposition of synthetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults. Journal of Pharmacokinetics and Bio-pharmaceutics 7: 249–264, 1979

    Article  CAS  Google Scholar 

  • Vaughan DP, Hope I. Application of recirculatory stochastic pharmacokinetics. Limitation of compartmental models. Journal of Pharmacokinetics and Biopharmaceutics 7: 207–225, 1979

    PubMed  CAS  Google Scholar 

  • Veng-Pedersen P. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. Journal of Pharmacokinetics and Biopharmaceutics 5: 513–531, 1977

    Google Scholar 

  • Veng-Pedersen P. General treatment of linear pharmacokinetics. Journal of Pharmaceutical Sciences 67: 187–191, 1978

    Article  Google Scholar 

  • Veng-Pedersen P. An algorithm and computer program for de-convolution in linear pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 8: 463–481, 1980

    PubMed  CAS  Google Scholar 

  • Veng-Pedersen P. Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions I. Derivation and theoretical analysis. Journal of Pharmacokinetics and Biopharmaceutics 12: 627–647, 1984

    PubMed  CAS  Google Scholar 

  • Veng-Pedersen P. A simple method for obtaining the mean residence time of metabolites in the body. Journal of Pharmaceutical Sciences 75: 818–819, 1986

    Article  PubMed  CAS  Google Scholar 

  • Veng-Pedersen P. System approaches in pharmacokinetics I. Basic concepts. Journal of Clinical Pharmacokinetics 28: 1–7, 1988a

    CAS  Google Scholar 

  • Veng-Pedersen P. System approaches in pharmacokinetics II. Applications. Journal of Clinical Pharmacokinetics 28: 97–104, 1988b

    CAS  Google Scholar 

  • Veng-Pedersen P. Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations. Journal of Pharmacokinetics and Biopharmaceutics 16: 413–472, 1988

    PubMed  CAS  Google Scholar 

  • Veng-Pedersen P, Gillespie WR. Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug’s tissue distribution. Journal of Pharmacokinetics and Biopharmaceutics 12: 535–543, 1984

    PubMed  CAS  Google Scholar 

  • Veng-Pedersen P, Gillespie WR. The mean residence time of drugs in the systemic circulation. Journal of Pharmaceutical Sciences 74: 791–792, 1985

    Article  PubMed  CAS  Google Scholar 

  • Veng-Pedersen P, Gillespie WR. Single pass mean residence time in peripheral tissues: a distribution parameter intrinsic to the tissue affinity of a drug. Journal of Pharmaceutical Sciences 12: 1119–1126, 1986

    Article  Google Scholar 

  • Veng-Pedersen P, Gillespie WR. A method for evaluating the mean residence times of metabolites in the body, systemic circulation and the peripheral tissue not requiring separate i.v. administration of metabolite. Biopharmaceuticals and Drug Disposition 8: 395–401, 1987a

    Article  CAS  Google Scholar 

  • Veng-Pedersen P, Gillespie WR. Theorems and implications of a model indepenent elimination/distribution function decomposition of linear and some nonlinear drug dispositions III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics. Journal of Pharmacokinetics and Biopharmaceutics 15: 281–303, 1987b

    PubMed  CAS  Google Scholar 

  • Wagner JG. Dosing intervals based on mean residence times. Journal of Pharmaceutical Sciences 76: 35–38, 1987

    Article  PubMed  CAS  Google Scholar 

  • Wagner JG, Nelson E. Percent absorbed time plots derived from blood level and/or urinary excretion data. Journal of Pharmaceutical Sciences 52: 610–611, 1963

    Article  PubMed  CAS  Google Scholar 

  • Waterhouse C, Keilson J. Transfer times across the human body. Bulletin of Mathematical Biophysics 35: 33–44, 1972

    Article  Google Scholar 

  • Weiss M. Residence time and accumulation of drug in the body. International Journal of Clinical Pharmacology Therapy and Toxicology 19: 82–85, 1981a

    CAS  Google Scholar 

  • Weiss M. Residence time and accumulation of drugs in the body. Journal of Clinical Pharmacology 19: 82–85, 1981b

    Article  CAS  Google Scholar 

  • Weiss M. Moments of physiological transit time distributions and the time course of drug disposition in the body. Journal of Mathematical Biology 15: 305–318, 1982

    Article  PubMed  CAS  Google Scholar 

  • Weiss M. Moments of physiological transit time distributions and the time course of drug disposition in the body. Journal of Mathematical Biology 15: 305–318, 1982

    Article  PubMed  CAS  Google Scholar 

  • Weiss M. Hemodynamic influences upon the variance of disposition residence time distribution of drugs. Journal of Pharmacokinetics and Biopharmaceutics 11: 65–75, 1983a

    Google Scholar 

  • Weiss M. Use of gamma distributed residence times in pharmacokinetics. European Journal of Clinical Pharmacology 25: 695–702, 1983b

    Article  PubMed  CAS  Google Scholar 

  • Weiss M. A note on the role of generalized inverse Ganssian distribution of circulatory transit times in pharmacokinetics. Journal of Mathematical Biology 20: 95–102, 1984a

    Article  PubMed  CAS  Google Scholar 

  • Weiss M. Model-independent assessment of accumulation kinetics based on moments of drug disposition curves. European Journal of Clinical Pharmacology 27: 355–359, 1984b

    Article  PubMed  CAS  Google Scholar 

  • Weiss M. Definition of pharmacokinetic parameters: influence of the sampling site. Journal of Pharmacokinetics and Biopharmaceutics 12: 167–175, 1984c

    PubMed  CAS  Google Scholar 

  • Weiss M. Metabolite residence time: influence of the first-pass effect. British Journal of Clinical Pharmacology 22: 121–122, 1986a

    Article  PubMed  CAS  Google Scholar 

  • Weiss M. Generalization in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves. Journal of Pharmacokinetics and Biopharmaceutics 14: 635–657, 1986b

    PubMed  CAS  Google Scholar 

  • Weiss M. Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. II. Log-concave concentration-time curves following oral administration. Journal of Pharmacokinetics and Biopharmaceutics 15: 57–74, 1987

    PubMed  CAS  Google Scholar 

  • Weiss M, Förster W. Pharmacokinetic model based on circulatory transport. European Journal of Clinical Pharmacology 16: 287–293, 1979

    Article  Google Scholar 

  • Welling PG, Craig WA. Pharmacokinetics of intravenous erythromycin. Journal of Pharmaceutical Sciences 67: 1057–1058, 1978

    Article  PubMed  CAS  Google Scholar 

  • Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics 6: 547–558, 1978

    PubMed  CAS  Google Scholar 

  • Zieler KL. Circulation times and the theory of indicator dilution methods for determining blood flow and volume. In Handbook of physiology, sec 2, Vol. 1, pp. 586–615, American Physiology Society, Washington, 1962

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Iowa, Iowa City, Iowa, 52242, USA

    Peter Veng-Pedersen

Authors
  1. Peter Veng-Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veng-Pedersen, P. Mean Time Parameters in Pharmacokinetics. Clin-Pharmacokinet 17, 424–440 (1989). https://doi.org/10.2165/00003088-198917060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198917060-00005

Keywords

Search

Navigation